Were you not one of those that professed how great the SAVA ex-CEO was because he knew the right way to manage a pre-revenue biotech company with "transparency" towards the shareholders, especially at $120+/share ... while never questioning the compensation structure that was based on how high the SP went?
So, forgive me if I and many others on this board take your thoughts about CEO's with a grain of salt ... or make it a pound for me.
Market Data 
Markets 
AI
